Join
Live feed
·
INSIDERFilingvia Quantisnow
Inhibrx Biosciences Inc. logo

Chief Executive Officer Lappe Mark bought $2,645,399 worth of shares (25,000 units at $105.82) (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
INBX· Inhibrx Biosciences Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track INBX (Inhibrx Biosciences Inc.) and more on Quantisnow.